Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Common Equity (2019 - 2026)

Valneva SE (VALN) posted Common Equity of $89.8 million for Q1 2026, down 27.34% sequentially from $123.6 million in Q4 2025, and down 51.29% YoY from $184.3 million in Q1 2025.

Analysis

Valneva SE (VALN) Common Equity (2019 - 2026) Analysis & Trends

Valneva SE has reported Common Equity for 8 years, with the latest figure at $89.8 million in Q1 2026.

  • Quarterly Common Equity fell 51.29% year-over-year to $89.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.8 million (down 51.29% YoY) and the FY2025 annual result came in at $123.6 million, down 37.0% from the prior year.
  • Common Equity fell to $89.8 million in Q1 2026 per VALN's latest filing, from $123.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $238.8 million in Q3 2024 and troughed at $17.7 million in Q3 2022.
  • A 5-year average of $154.0 million and a median of $179.1 million in 2024 frame the typical range for Common Equity.
  • The widest YoY moves for Common Equity: up 1141.77% in 2022, down 95.42% in 2022.
  • Over 5 years, Common Equity stood at $224.2 million in 2022, then tumbled by 38.47% to $138.0 million in 2023, then soared by 40.37% to $193.7 million in 2024, then tumbled by 36.19% to $123.6 million in 2025, then declined by 27.34% to $89.8 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $89.8 million, $123.6 million, and $175.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 94.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.29 Mn
Mar 31, 2026 89.80 Mn
Dec 31, 2025 123.58 Mn
Sep 30, 2025 175.92 Mn
Jun 30, 2025 211.03 Mn
Mar 31, 2025 184.35 Mn
Dec 31, 2024 193.69 Mn
Sep 30, 2024 238.83 Mn
Jun 30, 2024 179.06 Mn
Mar 31, 2024 205.57 Mn
Dec 31, 2023 137.99 Mn
Sep 30, 2023 646.63 Mn
Jun 30, 2023 207.67 Mn
Mar 31, 2023 219.80 Mn
Dec 31, 2022 606.07 Mn
Sep 30, 2022 17.75 Mn
Jun 30, 2022 18.78 Mn
Mar 31, 2022 166.56 Mn
Dec 31, 2021 18.06 Mn
Jun 30, 2021 92.81 Mn